Oneview Healthcare Reports 21% Revenue Growth in 2025

The healthcare software company highlighted accelerating deployment activity, continued U.S. focus, and a growing role for AI in product development and operations.

Published on Feb. 12, 2026

Got story updates? Submit your updates here. ›

Oneview Healthcare (ASX:ONE) reported full-year 2025 results, posting a 21% increase in revenue compared to 2024. The company attributed the growth to an increase in non-recurring revenue and 7% growth in annual recurring revenue, supported by the addition of 18 new logos over the past few years. Management also outlined product, commercial, and cost initiatives, including a reduction in operating expenses in the second half following a restructuring executed in May 2025.

Why it matters

Oneview Healthcare's strong financial performance and strategic initiatives demonstrate its ability to navigate the evolving healthcare technology landscape. The company's focus on expanding its customer base, improving operational efficiency, and leveraging AI in product development could position it for continued growth in the coming years.

The details

Oneview Healthcare reported a 21% increase in revenue in 2025 versus 2024, driven by an increase in non-recurring revenue and 7% growth in annual recurring revenue. The company added 18 new logos over the past few years, contributing to the revenue growth. However, gross margin declined by 3 percentage points to 64%, which the CFO attributed to revenue mix, as non-recurring revenue carries lower margins than recurring revenue. The company's operating EBITDA loss improved by 8% to EUR 8.1 million, which the CFO said was due to higher revenue while cash operating expenses remained consistent with 2024. Management highlighted a reduction in operating expenses in the second half following a restructuring executed in May 2025, with H2 2025 cash OpEx 9% lower than H1 2025 and 13% lower than H2 2024.

  • Oneview Healthcare reported full-year 2025 results (year ended December 2025).
  • The company executed a restructuring in May 2025, leading to a reduction in operating expenses in the second half of the year.
  • Oneview Healthcare ended 2025 with 14,800 live endpoints, with a target of just under 18,000 by the end of 2026.

The players

Oneview Healthcare

An Australian healthcare software company that develops and sells software and related consultancy services for the healthcare sector.

Darragh Lyons

The Chief Financial Officer of Oneview Healthcare.

James Fitter

The Chief Executive Officer of Oneview Healthcare.

Niall O'Neill

The Chief Product Officer of Oneview Healthcare.

Michael Dowling

The CEO for the past 23 years of a large New York health system, who was recently added to Oneview Healthcare's board.

Got photos? Submit your photos here. ›

What they’re saying

“We must not let individuals continue to damage private property in San Francisco.”

— Robert Jenkins, San Francisco resident (San Francisco Chronicle)

“Fifty years is such an accomplishment in San Francisco, especially with the way the city has changed over the years.”

— Gordon Edgar, grocery employee (Instagram)

What’s next

The judge in the case will decide on Tuesday whether or not to allow Walker Reed Quinn out on bail.

The takeaway

This case highlights growing concerns in the community about repeat offenders released on bail, raising questions about bail reform, public safety on SF streets, and if any special laws to govern autonomous vehicles in residential and commercial areas.